Price regulation of pharmaceuticals in Canada

Journal of Health Economics

Volumn 17, Issue 1, 1998, Pages 21-38

  Anis, Aslam H ^b   Quan, Wen ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Competition policy; Pharmaceutical price regulation; Pharmacoeconomics

Indexed keywords

ARTICLE; CANADA; DRUG COST; PHARMACOECONOMICS; REGULATORY MECHANISM;

CANADA; DRUG COSTS; DRUG INDUSTRY; ECONOMIC COMPETITION; GUIDELINES; MODELS, ECONOMETRIC; PATENTS; RATE SETTING AND REVIEW;

EID: 0031972566     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-6296(97)00016-7     Document Type: Article

References (11)

1. Anis, A.H., 1992. Pharmaceutical prices with insurance coverage and formularies. Can. J. Econ. 25, 420-437.
2. Anis, A.H., 1994. Substitution laws, insurance coverage, and generic drug use. Medical Care 32 (3), 240-256.
3. Carroll, N.V., Fincham, J.E., Cox, F.M., 1987. The effects of differences in state drug product selection laws on pharmacists' substitution behaviour. Medical Care 25 (11), 1069-1074.
4. Detsky, A., 1993. Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada. PharmacoEconomics 3 (5), 354-361.
5. GAO/HRD-92-110, 1992. Prescription Drugs Companies Typically Charge more in the United States than in Canada.
6. Hsiao, C., 1986. Analysis of Panel Data. Cambridge Univ. Press.
7. Liang, K.-Y., Zeger, S.L., 1986. Longitudinal data analysis using generalized linear models. Biometrika 73 (1), 13-22.
8. Lipsy, R.G., 1992. Institutional formularies, the relevance of pharmacoeconomic analysis to formulary decisions. PharmacoEconomics 1 (4), 265-281.
9. Patented Medicines Prices Review Board, 1988. Bull.: the first issue.
10. Patented Medicines Prices Review Board, 1993. Int. Price Comparison Studies.
11. Patented Medicines Prices Review Board, 1993. Bull. Issue No. 12.